Ukrain: a novel antitumor drug
Uglyanitsa, K.N.; Nefyodov, L.I.; Doroshenko, Y.M.; Nowicky, J.W.; Volchek, I.V.; Brzosko, W.J.; Hodysh, Y.J.
Drugs under Experimental and Clinical Research 26(5-6): 341-356
2000
ISSN/ISBN: 0378-6501 PMID: 11345050 Document Number: 517614
A review of the recent literature on the new anticancer drug Ukrain is provided herein. We review Ukrain, a thiophosphate derivative of alkaloids from Chelidonium majus L., its capacity to exert selective cytotoxic and cytostatic effects on tumor cells, simultaneously acting as an immune response modifier, its good tolerance and lack of side effects even after long-term application, perspectives of the application of this drug in oncology.
Document emailed within 1 workday
Related Documents
Bozeman, E.N.; Srivatsan, S.; Mohammadi, H.; Daniels, D.; Shashidharamurthy, R.; Selvaraj, P. 2012: Ukrain, a plant derived semi-synthetic compound, exerts antitumor effects against murine and human breast cancer and induce protective antitumor immunity in mice Experimental Oncology 34(4): 340-347Luksa-Lichtenthaeler, G.L.; Ladutko, E.I.; Nowicky, J.W. 2000: Radiomodification effects of Ukrain, a cytostatic and immunomodulating drug, on intracellular glucocorticoid reception during short-term gamma-irradiation Drugs under Experimental and Clinical Research 26(5-6): 311-315
Shao, C.; Xu, S.; Song, Y.; Zhu, D. 2017: Screening of antitumor polypeptide drug and enhanced CT imaging based on drug target analysis Pakistan Journal of Pharmaceutical Sciences 30(5(Special): 1883-1888
Ogawa, Y.; Toguchi, H. 1990: Targeting therapy with a drug using temperature-sensitive liposomes entrapped antitumor drug together with localized hyperthermia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(6): 1127-1133
Maftouh, M.; Monsarrat, B.; Rao, R.C.; Meunier, B.; Paoletti, C. 1984: Identification of the glucuronide and glutathione conjugates of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate (Celiptium). Comparative disposition of this drug with its olivacinium isomer in rat bile Drug Metabolism and Disposition: the Biological Fate of Chemicals 12(1): 111-119
Carrasco, C.; Vezin, H.; Wilson, W.D.; Ren, J.; Chaires, J.B.; Bailly, C. 2001: DNA binding properties of the indolocarbazole antitumor drug NB-506 Anti-Cancer Drug Design 16(2-3): 99-107
Banovic, P.; Stankov, S.; Vranjes, N.; Zurkovic, O.; Capo, I.; Lalosevic, D. 2018: Drug repurposing: mebendazole as effective antitumor agent. Are we seeing the whole story? Journal of BUON: Official Journal of the Balkan Union of Oncology 23(6): 1904-1911
Liping, S.; Tingting, C.; Zheng, Y.; Tian, X.; Haibo, C. 2018: Apoptosis and antitumor effects between β-elemene and astragaloside and drug mechanism analysis Pakistan Journal of Pharmaceutical Sciences 31(5(Special): 2271-2276
Imasaka, K.; Ueda, H.; Azuma, T.; Kawaguchi, T.; Nagai, T. 1989: Application of new silicone gel to sustained release dosage form of antitumor drug Drug Design and Delivery 4(3): 237-246
Horspool, K.R.; Quarterman, C.P.; Slack, J.A.; Gescher, A.; Stevens, M.F.; Lunt, E. 1989: Metabolism and murine pharmacokinetics of the 8-(N,N-dimethylcarboxamide) analogue of the experimental antitumor drug mitozolomide (NSC353451) Cancer Research 49(18): 5023-5026
Li, H.; Wang, Z.; Yue, B.; Zou, F.; Yang, K.; Sun, J.; Wang, B.; Zhang, H.; Chen, H.; Yang, G. 2003: Study of high-intensity electric pulse inhibited sarcoma for improving antitumor drug effect Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 20(4): 612-614
Maehara, Y.; Anai, H.; Kusumoto, T.; Sakaguchi, Y.; Emi, Y.; Kohnoe, S.; Sugimachi, K. 1989: Detection of cellular DNA strand breaks induced by antitumor drug and heat using in situ nick translation Nihon Geka Gakkai Zasshi 90(9): 1576-1578
Rene, B.; Fosse, P.; Khelifa, T.; Jacquemin-Sablon, A.; Bailly, C. 1996: The 1'-substituent on the anilino ring of the antitumor drug amsacrine is a critical element for topoisomerase II inhibition and cytotoxicity Molecular Pharmacology 49(2): 343-350
Smyth, M.J.; Pietersz, G.A.; McKenzie, I.F. 1987: Use of vasoactive agents to increase tumor perfusion and the antitumor efficacy of drug-monoclonal antibody conjugates Journal of the National Cancer Institute 79(6): 1367-1373
Onishi, H.; Seno, Y.; Pithayanukul, P.; Nagai, T. 1991: Conjugate of N4-(4-carboxybutyryl)-ara-C and ethylenediamine-introduced dextran. Drug release profiles and further in vivo study of its antitumor effects Drug Design and Delivery 7(2): 139-145
Kuroiwa, S.; Koyama, M.; Watanabe, N.; Ekimoto, H.; Ohnishi, Y.; Saito, M.; Maruo, K.; Inaba, M.; Tashiro, T.; Yamori, T. 1993: Antitumor activity of a new antiestrogenic drug, toremifene (NK622) against human breast cancer xenografts in nude mice Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(5): 617-623
Ebina, T.; Shishido, K.; Murata, K. 1990: Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(7): 1345-1350
Hrabowska, M.; Ledóchowski, A.; Stefańska, B.; Onoszko, K. 1970: A search for antitumor compounds. 8. Biologic studies. Antitumor properties of 17 new 1-nitro-9-aminoacridine derivatives Archivum Immunologiae et Therapiae Experimentalis 18(5): 557-570
Yokoyama, M.; Okano, T.; Sakurai, Y.; Ekimoto, H.; Shibazaki, C.; Kataoka, K. 1991: Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood Cancer Research 51(12): 3229-3236
Otake, N. 1988: The structure and antitumor activity of antitumor antibiotics--recent progress Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 369-379